Induced pluripotent stem cells: developmental biology to regenerative medicine (original) (raw)

• Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
  CAS PubMed Google Scholar
• Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
  CAS PubMed Google Scholar
• Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
  CAS PubMed Google Scholar
• Meissner, A., Wernig, M. & Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25, 1177–1181 (2007).
  CAS PubMed Google Scholar
• Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008).
  CAS PubMed PubMed Central Google Scholar
• Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567–582 (2008).
  CAS PubMed PubMed Central Google Scholar
• Murry, C. E. & Keller, G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132, 661–680 (2008).
  CAS PubMed Google Scholar
• Yamanaka, S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1, 39–49 (2007).
  CAS PubMed Google Scholar
• Park, I. H., Lerou, P. H., Zhao, R., Huo, H. & Daley, G. Q. Generation of human-induced pluripotent stem cells. Nat. Protoc. 3, 1180–1186 (2008).
  CAS PubMed Google Scholar
• Yamanaka, S. & Blau, H. M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 465, 704–712 (2010).
  CAS PubMed PubMed Central Google Scholar
• Nelson, T., Behfar, A. & Terzic, A. Stem cells: biologics for regeneration. Clin. Pharmacol. Ther. 84, 620–623 (2008).
  CAS PubMed Google Scholar
• Nelson, T. J., Behfar, A. & Terzic, A. Strategies for therapeutic repair: the “R3” regenerative medicine paradigm. Clin. Transl. Sci. 1, 168–171 (2008).
  PubMed PubMed Central Google Scholar
• Raya, A. et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53–59 (2009).
  CAS PubMed PubMed Central Google Scholar
• Lee, G. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402–406 (2009).
  CAS PubMed PubMed Central Google Scholar
• Nelson, T. J., Behfar, A., Yamada, S., Martinez-Fernandez, A. & Terzic, A. Stem cell platforms for regenerative medicine. Clin. Transl. Sci. 2, 222–227 (2009).
  CAS PubMed PubMed Central Google Scholar
• Wu, J. C., Abraham, M. R. & Kraitchman, D. L. Current perspectives on imaging cardiac stem cell therapy. J. Nucl. Med. 51 (Suppl. 1), 128S–136S (2010).
• Parker, A. et al. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients—BCSH and BTS Guidelines. Br. J. Haematol. 149, 675–692 (2010).
  PubMed Google Scholar
• Martinez, O. M. & de Gruijl, F. R. Molecular and immunologic mechanisms of cancer pathogenesis in solid organ transplant recipients. Am. J. Transplant. 8, 2205–2211 (2008).
  CAS PubMed Google Scholar
• Silva, J. & Smith, A. Capturing pluripotency. Cell 132, 532–536 (2008).
  CAS PubMed PubMed Central Google Scholar
• Campbell, K. H., McWhir, J., Ritchie, W. A. & Wilmut, I. Sheep cloned by nuclear transfer from a cultured cell line. Nature 380, 64–66 (1996).
  CAS PubMed Google Scholar
• Beyhan, Z., Iager, A. E. & Cibelli, J. B. Interspecies nuclear transfer: implications for embryonic stem cell biology. Cell Stem Cell 1, 502–512 (2007).
  CAS PubMed Google Scholar
• Byrne, J. A. et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450, 497–502 (2007).
  CAS PubMed Google Scholar
• French, A. J. et al. Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells 26, 485–493 (2008).
  CAS PubMed Google Scholar
• Yamanaka, S. Pluripotency and nuclear reprogramming. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 2079–2087 (2008).
  CAS PubMed PubMed Central Google Scholar
• Yamanaka, S. A fresh look at iPS cells. Cell 137, 13–17 (2009).
  CAS PubMed Google Scholar
• Yamanaka, S. Elite and stochastic models for induced pluripotent stem cell generation. Nature 460, 49–52 (2009).
  CAS PubMed Google Scholar
• Dimos, J. T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218–1221 (2008).
  CAS PubMed Google Scholar
• Ebert, A. D. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277–280 (2009).
  CAS PubMed Google Scholar
• Takahashi, K., Okita, K., Nakagawa, M. & Yamanaka, S. Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc. 2, 3081–3089 (2007).
  CAS PubMed Google Scholar
• Aasen, T. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276–1284 (2008).
  CAS PubMed Google Scholar
• Eminli, S. et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet. 41, 968–976 (2009).
  CAS PubMed PubMed Central Google Scholar
• Sun, N. et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl Acad. Sci. USA 106, 15720–15725 (2009).
  CAS PubMed PubMed Central Google Scholar
• Marion, R. M. et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141–154 (2009).
  CAS PubMed Google Scholar
• Deng, J. et al. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat. Biotechnol. 27, 353–360 (2009).
  CAS PubMed PubMed Central Google Scholar
• Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49–55 (2008).
  CAS PubMed PubMed Central Google Scholar
• Silva, J. et al. Nanog is the gateway to the pluripotent ground state. Cell 138, 722–737 (2009).
  CAS PubMed PubMed Central Google Scholar
• Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T. & Yamanaka, S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5, 237–241 (2009).
  CAS PubMed Google Scholar
• Huangfu, D. et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26, 795–797 (2008).
  CAS PubMed PubMed Central Google Scholar
• Lin, T. et al. A chemical platform for improved induction of human iPSCs. Nat. Methods 6, 805–808 (2009).
  CAS PubMed PubMed Central Google Scholar
• Banito, A. et al. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 23, 2134–2139 (2009).
  CAS PubMed PubMed Central Google Scholar
• Utikal, J. et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460, 1145–1148 (2009).
  CAS PubMed PubMed Central Google Scholar
• Marión, R. M. et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149–1153 (2009).
  PubMed PubMed Central Google Scholar
• Li, H. et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460, 1136–1139 (2009).
  CAS PubMed PubMed Central Google Scholar
• Kawamura, T. et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460, 1140–1144 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132–1135 (2009).
  CAS PubMed PubMed Central Google Scholar
• Smith, Z. D., Nachman, I., Regev, A. & Meissner, A. Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat. Biotechnol. 28, 521–526 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595–601 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hotta, A. & Ellis, J. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. J. Cell. Biochem. 105, 940–948 (2008).
  CAS PubMed Google Scholar
• Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945–949 (2008).
  CAS PubMed PubMed Central Google Scholar
• Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949–953 (2008).
  CAS PubMed Google Scholar
• Chang, C. W. et al. Polycistronic lentiviral vector for “hit and run” reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 27, 1042–1049 (2009).
  CAS PubMed Google Scholar
• Kaji, K. et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771–775 (2009).
  CAS PubMed PubMed Central Google Scholar
• Woltjen, K. et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766–770 (2009).
  CAS PubMed PubMed Central Google Scholar
• Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797–801 (2009).
  CAS PubMed PubMed Central Google Scholar
• Zhou, H. et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381–384 (2009).
  CAS PubMed Google Scholar
• Kim, D. et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472–476 (2009).
  CAS PubMed PubMed Central Google Scholar
• Schenke-Layland, K. et al. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 26, 1537–1546 (2008).
  CAS PubMed PubMed Central Google Scholar
• Martinez-Fernandez, A. et al. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circ. Res. 105, 648–656 (2009).
  CAS PubMed PubMed Central Google Scholar
• Mauritz, C. et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118, 507–517 (2008).
  PubMed Google Scholar
• Narazaki, G. et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118, 498–506 (2008).
  PubMed Google Scholar
• Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30–e41 (2009).
  CAS PubMed PubMed Central Google Scholar
• Tashiro, K. et al. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 27, 1802–1811 (2009).
  CAS PubMed Google Scholar
• Niwa, A. et al. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1+ hemoangiogenic progenitors. J. Cell. Physiol. 221, 367–377 (2009).
  CAS PubMed Google Scholar
• Senju, S. et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 27, 1021–1031 (2009).
  CAS PubMed Google Scholar
• Maehr, R. et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl Acad. Sci. USA 106, 15768–15773 (2009).
  CAS PubMed PubMed Central Google Scholar
• Tateishi, K. et al. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J. Biol. Chem. 283, 31601–31607 (2008).
  CAS PubMed Google Scholar
• Zhang, D. et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 19, 429–438 (2009).
  CAS PubMed Google Scholar
• Si-Tayeb, K. et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51, 297–305 (2010).
  CAS PubMed Google Scholar
• Song, Z. et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 19, 1233–1242 (2009).
  PubMed Google Scholar
• Buchholz, D. E. et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 27, 2427–2434 (2009).
  CAS PubMed Google Scholar
• Meyer, J. S. et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 106, 16698–16703 (2009).
  CAS PubMed PubMed Central Google Scholar
• Osakada, F. et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J. Cell Sci. 122, 3169–3179 (2009).
  CAS PubMed Google Scholar
• Karumbayaram, S. et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 27, 806–811 (2009).
  CAS PubMed PubMed Central Google Scholar
• Smith, K. P., Luong, M. X. & Stein, G. S. Pluripotency: toward a gold standard for human ES and iPS cells. J. Cell. Physiol. 220, 21–29 (2009).
  CAS PubMed Google Scholar
• Nelson, T. J., Martinez-Fernandez, A. & Terzic, A. KCNJ11 knockout morula re-engineered by stem cell diploid aggregation. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 269–276 (2009).
  CAS PubMed Google Scholar
• Nagy, A., Nagy, K. & Gertsenstein, M. Production of mouse chimeras by aggregating pluripotent stem cells with embryos. Methods Enzymol. 476, 123–149 (2010).
  CAS PubMed Google Scholar
• Zhao, X. Y. et al. iPS cells produce viable mice through tetraploid complementation. Nature 461, 86–90 (2009).
  CAS PubMed Google Scholar
• Stadtfeld, M. et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175–181 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hanna, J. et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920–1923 (2007).
  CAS PubMed Google Scholar
• Xu, D. et al. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc. Natl Acad. Sci. USA 106, 808–813 (2009).
  CAS PubMed PubMed Central Google Scholar
• Wernig, M. et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 5856–5861 (2008).
  CAS PubMed PubMed Central Google Scholar
• Nelson, T. J. et al. Repair of acute myocardial infarction with human stemness factors induced pluripotent stem cells. Circulation 120, 408–416 (2009).
  PubMed PubMed Central Google Scholar
• Ye, Z. et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114, 5473–5480 (2009).
  CAS PubMed PubMed Central Google Scholar
• Chien, K. R., Domian, I. J. & Parker, K. K. Cardiogenesis and the complex biology of regenerative cardiovascular medicine. Science 322, 1494–1497 (2008).
  CAS PubMed Google Scholar
• Slack, J. M. Origin of stem cells in organogenesis. Science 322, 1498–1501 (2008).
  CAS PubMed Google Scholar
• Garry, D. J. & Olson, E. N. A common progenitor at the heart of development. Cell 127, 1101–1104 (2006).
  CAS PubMed Google Scholar
• Laflamme, M. A. & Murry, C. E. Regenerating the heart. Nat. Biotechnol. 23, 845–856 (2005).
  CAS PubMed Google Scholar
• Wu, S. M., Chien, K. R. & Mummery, C. Origins and fates of cardiovascular progenitor cells. Cell 132, 537–543 (2008).
  CAS PubMed PubMed Central Google Scholar
• Mummery, C. et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107, 2733–2740 (2003).
  CAS PubMed Google Scholar
• Schneider, V. A. & Mercola, M. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev. 15, 304–315 (2001).
  CAS PubMed PubMed Central Google Scholar
• Marvin, M. J., Di Rocco, G., Gardiner, A., Bush, S. M. & Lassar, A. B. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev. 15, 316–327 (2001).
  CAS PubMed PubMed Central Google Scholar
• Olson, E. N. Development. The path to the heart and the road not taken. Science 291, 2327–2378 (2001).
  CAS PubMed Google Scholar
• Pashmforoush, M. et al. Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117, 373–386 (2004).
  CAS PubMed Google Scholar
• Ishiwata, T., Nakazawa, M., Pu, W. T., Tevosian, S. G. & Izumo, S. Developmental changes in ventricular diastolic function correlate with changes in ventricular myoarchitecture in normal mouse embryos. Circ. Res. 93, 857–865 (2003).
  CAS PubMed Google Scholar
• Zhou, B. et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454, 109–113 (2008).
  CAS PubMed PubMed Central Google Scholar
• Christoffels, V. M. et al. Tbx18 and the fate of epicardial progenitors. Nature 458, E8–E9 (2009).
  CAS PubMed Google Scholar
• Moskowitz, I. P. et al. A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development. Cell 129, 1365–1376 (2007).
  CAS PubMed Google Scholar
• Zhao, Y. et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129, 303–317 (2007).
  CAS PubMed Google Scholar
• Rentschler, S. et al. Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc. Natl Acad. Sci. USA 99, 10464–10469 (2002).
  CAS PubMed PubMed Central Google Scholar
• Siedner, S. et al. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J. Physiol. 548, 493–505 (2003).
  CAS PubMed PubMed Central Google Scholar
• MacLellan, W. R. & Schneider, M. D. Genetic dissection of cardiac growth control pathways. Annu. Rev. Physiol. 62, 289–319 (2000).
  CAS PubMed Google Scholar
• Gai, H. et al. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol. Int. 33, 1184–1193 (2009).
  CAS PubMed Google Scholar
• Kuzmenkin, A. et al. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J. 23, 4168–4180 (2009).
  CAS PubMed Google Scholar
• Martinez-Fernandez, A., Nelson, T. J., Ikeda, Y. & Terzic, A. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. J. Cardiovasc. Transl. Res. 3, 13–23 (2010).
  PubMed PubMed Central Google Scholar
• Zwi, L. et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120, 1513–1523 (2009).
  CAS PubMed Google Scholar
• Moretti, A. et al. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J. 24, 700–711 (2010).
  CAS PubMed Google Scholar
• Yokoo, N. et al. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem. Biophys. Res. Commun. 387, 482–488 (2009).
  CAS PubMed Google Scholar
• Pfannkuche, K. et al. Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. Cell. Physiol. Biochem. 24, 73–86 (2009).
  CAS PubMed Google Scholar
• Moretti, A. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. doi:10.1056/NEJMoa0908679.
  CAS Google Scholar
• Carvajal-Vergara, X. et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465, 808–812 (2010).
  CAS PubMed PubMed Central Google Scholar
• Hansen, A. et al. Development of a drug screening platform based on engineered heart tissue. Circ. Res. 107, 35–44 (2010).
  CAS PubMed Google Scholar
• Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375–386 (2010).
  CAS PubMed PubMed Central Google Scholar
• van Laake, L. W. et al. Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance. Circ. Res. 107, 340–347 (2010).
  CAS PubMed PubMed Central Google Scholar
• Srinivas, G., Anversa, P. & Frishman, W. H. Cytokines and myocardial regeneration: a novel treatment option for acute myocardial infarction. Cardiol. Rev. 17, 1–9 (2009).
  PubMed Google Scholar
• Reinecke, H., Minami, E., Zhu, W. Z. & Laflamme, M. A. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ. Res. 103, 1058–1071 (2008).
  CAS PubMed PubMed Central Google Scholar
• Bartunek, J. et al. Delivery of biologics in cardiovascular regenerative medicine. Clin. Pharmacol. Ther. 85, 548–552 (2009).
  CAS PubMed Google Scholar
• Blin, G. et al. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J. Clin. Invest. 120, 1125–1139 (2010).
  CAS PubMed PubMed Central Google Scholar
• Alper, J. Geron gets green light for human trial of ES cell-derived product. Nat. Biotechnol. 27, 213–214 (2009).
  CAS PubMed Google Scholar
• Li, J. Y., Christophersen, N. S., Hall, V., Soulet, D. & Brundin, P. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci. 31, 146–153 (2008).
  PubMed Google Scholar
• Olson, E. N. A decade of discoveries in cardiac biology. Nat. Med. 10, 467–474 (2004).
  CAS PubMed Google Scholar
• Behfar, A. et al. Guided stem cell cardiopoiesis: discovery and translation. J. Mol. Cell. Cardiol. 45, 523–529 (2008).
  CAS PubMed PubMed Central Google Scholar
• Behfar, A. et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J. Exp. Med. 204, 405–420 (2007).
  CAS PubMed PubMed Central Google Scholar
• Chiriac, A., Nelson, T. J., Faustino, R. S., Behfar, A. & Terzic, A. Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1/VEGF/BMP2 integrated network. PLoS ONE 5, e9943 (2010).
  PubMed PubMed Central Google Scholar
• Nelson, T. J. et al. CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. Stem Cells 26, 1464–1473 (2008).
  CAS PubMed Google Scholar
• Moretti, A. et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 1151–1165 (2006).
  CAS PubMed Google Scholar
• Kattman, S. J., Huber, T. L. & Keller, G. M. Multipotent Flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev. Cell 11, 723–732 (2006).
  CAS PubMed Google Scholar
• Yang, L. et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453, 524–528 (2008).
  CAS PubMed Google Scholar
• Takeuchi, J. K. & Bruneau, B. G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 459, 708–711 (2009).
  CAS PubMed PubMed Central Google Scholar
• Padin-Iruegas, M. E. et al. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 120, 876–887 (2009).
  CAS PubMed PubMed Central Google Scholar
• Terzic, A. & Nelson, T. J. Regenerative medicine advancing health care 2020. J. Am. Coll. Cardiol. 55, 2254–2257 (2010).
  PubMed Google Scholar
• Yoshida, Y. & Yamanaka, S. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation 122, 80–87 (2010).
  PubMed Google Scholar